Campath and Voriconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Voriconazole (voriconazole). Common drug interactions include abdominal pain lower among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Voriconazole. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Voriconazole?

Voriconazole has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 21,706 Voriconazole users. Check the latest studies of Voriconazole.

On Jul, 16, 2026

44 people who take Campath and Voriconazole together, and have interactions are studied.

Campath and Voriconazole drug interactions.

What are the common drug interactions of Campath and Voriconazole, by gender? *:

female:

Abdominal pain lower
Activities of daily living impaired
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Anaemia (lack of blood)
Aphasia (damage to the parts of the brain that control language)
Ataxia (loss of full control of bodily movements)
Bk virus infection
Blood creatinine increased
Chills (felling of cold)
Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)

male:

Sinusitis (inflammation of sinus)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Hemiplegia (paralysis of one side of the body)
Hydrocephalus (water on the brain)
Hypertension (high blood pressure)
Hypertensive crisis
Loss of consciousness
Neurological decompensation (inability of brain to maintain proper function)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Campath and Voriconazole, by age (0-1 to 60+)? *:

0-1:

Septic shock (shock due to blood infection)
Pyrexia (fever)
Drug level increased
Pulmonary mass
Adenovirus infection
Altered state of consciousness (altered state of mind)
Blood creatinine increased
Cerebral aspergillosis (pus collection with swelling in brain)
Cerebral disorder (brain disease)
Chronic graft versus host disease in skin (damage by immune cells to skin after grafting)

2-9:

n/a

10-19:

Adenovirus infection
Epstein-barr viraemia

20-29:

Abdominal pain
Alanine aminotransferase increased
Aspartate aminotransferase increased
Diarrhoea
Infection
Fungal abscess central nervous system (collection of pus in brain by result of fungal infection)
Mediastinitis (inflammation of the tissues in the mid-chest)
Vascular pseudoaneurysm ruptured (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)

30-39:

Myositis (inflammation of the muscles)
Pneumonia
Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
Respiratory failure (inadequate gas exchange by the respiratory system)
Catheter sepsis (bacterial infection in blood due to catheter)
Cd4 lymphocytes decreased
Encephalitis allergic (inflammation of the brain due to allergy)
Encephalitis viral (inflammation of the brain due to viral infection)
Lung transplant rejection (failure of lung transplant)
Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)

40-49:

Confusional state
Encephalopathy (functioning of the brain is affected by some agent or condition)
Somnolence (a state of near-sleep, a strong desire for sleep)
Stem cell transplant

50-59:

Nausea (feeling of having an urge to vomit)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Septic shock (shock due to blood infection)
Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Lung infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Transplant failure (transplantation failed to meet outcome)
Abdominal discomfort

60+:

Sinusitis (inflammation of sinus)
Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Ascites (accumulation of fluid in the abdominal cavity)
Bone marrow failure
Dehydration (dryness resulting from the removal of water)
Fungal infection
General physical health deterioration (weak health status)
Gravitational oedema (abnormally large fluid volume in the circulatory system makes obese)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Fever: 8 people, 18.18%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 13.64%
Chronic Granulomatous Disease (immune system cells are unable to kill some types of bacteria and fungi): 5 people, 11.36%
Bone Marrow Conditioning Regimen: 5 people, 11.36%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 11.36%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 5 people, 11.36%
Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 4 people, 9.09%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 3 people, 6.82%
Pulmonary Mass: 3 people, 6.82%
Fungal Infection: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Voriconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously